Home | News | Videos | The CNIO develops an anti-obesity treatment in animal models

The CNIO develops an anti-obesity treatment in animal models

26.03.2015

Support Cancer Research

Obesity is one of the top risk factors within the spectrum of serious diseases that constitute metabolic syndrome. A team of the Tumour Supression Group at the CNIO could reduce it in animal models using a drug which inhibits the activity of the PI3K enzyme.

Back to the news

Up